Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population"

メタデータ

公開日
2023-01-01
DOI
  • 10.6084/m9.figshare.21876159
  • 10.6084/m9.figshare.21876159.v2
  • 10.6084/m9.figshare.21876159.v3
  • 10.6084/m9.figshare.21876159.v1
公開者
figshare
データ作成者 (e-Rad)
  • Kawasaki, Aya
  • Sada, Ken-Ei
  • Kusumawati, Premita Ari
  • Hirano, Fumio
  • Kobayashi, Shigeto
  • Nagasaka, Kenji
  • Sugihara, Takahiko
  • Ono, Nobuyuki
  • Fujimoto, Takashi
  • Kusaoi, Makio
  • Tamura, Naoto
  • Kusanagi, Yasuyoshi
  • Itoh, Kenji
  • Sumida, Takayuki
  • Yamagata, Kunihiro
  • Hashimoto, Hiroshi
  • Makino, Hirofumi
  • Arimura, Yoshihiro
  • Harigai, Masayoshi
  • Tsuchiya, Naoyuki

説明

Supplementary Table S1. Association analysis of each HLA-DRB1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S2. Association analysis of each HLA-DQA1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S3. Association analysis of each HLA-DQB1 allele with occurrence of relapse and time to relapse. <br> Supplementary Table S4. Association analysis of each HLA-DPB1 allele with occurrence of relapse and time to relapse. Supplementary Table S5 Association analyses of HLA-DRβ1_13S encoding alleles with susceptibility and relapse-free survival. Supplementary Figure S1. Sanger sequencing chromatograms around the HLA-DQA1*03:02 tagSNP rs11545686. Representative Sanger sequencing chromatograms corresponding to each of the three genotypes are shown. The rs11545686C allele tags HLA-DQA1*03:02. HLA-DQA1 genotype of each subject determined by PCR-SSOP was DQA1*03:02/03*02 (relapse ID 36), DQA1*03:02/05:07 (relapse ID 156) and DQA1* 01:01/01:02 (relapse ID 164), as shown in Supplementary Data 1. <br> Supplementary Data 1. Clinical information and HLA genotypes in each subject examined for susceptibility and relapse. <br> Susceptibility Data 2. Association of each HLA -class II amino acid with relapse-free survival. <br>

関連論文

もっと見る
ページトップへ